Citation 83933

KUROYANAGI,M: ARAKAWA,T: HIRAYAMA,Y: HAYASHI,T:. (1999). ANTIBACTERIAL AND ANTIANDROGEN FLAVONOIDS FROM SOPHORA FLAVESCENS.. 62(12)

Citation Details

Title	ANTIBACTERIAL AND ANTIANDROGEN FLAVONOIDS FROM SOPHORA FLAVESCENS.
Authors	KUROYANAGI,M: ARAKAWA,T: HIRAYAMA,Y: HAYASHI,T:
Year	1999
Volume	62
Issue	12

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Sophora flavescens (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHECARPIN A	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHECARPIN B	None
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KUSHECARPIN C	None
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KUSHENOL I	None
7	Not specified	ISOLATION AND IDENTIFICATION OF	MAACKIAIN,L:	None
8	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL P	None
9	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL P	WEAK ACTIVITY
10	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL P	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL Q	None
12	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL Q	WEAK ACTIVITY
13	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL Q	ACTIVE
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL Q	ACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL Q	ACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL R	None
17	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL R	WEAK ACTIVITY
18	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL R	WEAK ACTIVITY
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL R	ACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL R	ACTIVE
21	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL R	ACTIVE
22	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL R	ACTIVE
23	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL S	None
24	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL S	WEAK ACTIVITY
25	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL S	WEAK ACTIVITY
26	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL S	ACTIVE
27	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL S	ACTIVE
28	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL T	None
29	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL T	WEAK ACTIVITY
30	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL T	WEAK ACTIVITY
31	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL U	None
32	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL U	WEAK ACTIVITY
33	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL U	ACTIVE
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL U	ACTIVE
35	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL U	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL U	ACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL U	ACTIVE
38	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KUSHENOL V	None
39	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL V	ACTIVE
40	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL V	ACTIVE
41	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	KUSHENOL W	None
42	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL W	ACTIVE
43	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL W	ACTIVE
44	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	KUSHENOL X	None
45	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL X	WEAK ACTIVITY
46	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL X	ACTIVE
47	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL X	ACTIVE
48	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL X	ACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KURARINONE,NOR:	None
50	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,NOR:	ACTIVE
51	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,NOR:	ACTIVE
52	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,NOR:	ACTIVE
53	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,NOR:	ACTIVE
54	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,NOR:	ACTIVE
55	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,NOR:	ACTIVE
56	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KURARINONE	None
57	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE	WEAK ACTIVITY
58	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE	ACTIVE
59	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE	ACTIVE
60	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE	ACTIVE
61	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KURARINOL,NEO:	None
62	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NEO:	WEAK ACTIVITY
63	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NEO:	ACTIVE
64	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NEO:	ACTIVE
65	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NEO:	ACTIVE
66	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NEO:	ACTIVE
67	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NEO:	ACTIVE
68	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KURARINONE,ISO:	None
69	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,ISO:	ACTIVE
70	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,ISO:	ACTIVE
71	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,ISO:	ACTIVE
72	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,ISO:	ACTIVE
73	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,ISO:	ACTIVE
74	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINONE,ISO:	ACTIVE
75	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KURARINOL,NOR:	None
76	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NOR:	WEAK ACTIVITY
77	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL,NOR:	WEAK ACTIVITY
78	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KURARINOL	None
79	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL	INACTIVE
80	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KURARINOL	WEAK ACTIVITY
81	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KUSHENOL A	None
82	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL A	WEAK ACTIVITY
83	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL A	ACTIVE
84	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL A	ACTIVE
85	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL A	ACTIVE
86	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL A	ACTIVE
87	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL A	ACTIVE
88	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LEACHIANONE G	None
89	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LEACHIANONE G	WEAK ACTIVITY
90	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	LEACHIANONE G	ACTIVE
91	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LEACHIANONE G	ACTIVE
92	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LEACHIANONE G	ACTIVE
93	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KUSHENOL H	None
94	REDUCTASE,5-ALPHA: INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL H	WEAK ACTIVITY
95	RECEPTOR BINDING(ANDROGEN) DECREASED	PHARMACOLOGY OF COMPOUND - IN VITRO	KUSHENOL H	ACTIVE

Citation 83933

Citation Details

Summary

Organisms and Their Experiments (1)

Sophora flavescens (FABACEAE)

Show SPARQL Queries (1)

Query 1